Parkinson DiseaseNCT06482502
Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients
An observational study of Parkinson Disease, run by Emre Şenocak at 1 site in Turkey (Türkiye).
Trial summary
Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in… Read more about this study
- Who is it for?
- Ages 45 to 75 years
- Conditions the study is for
- Parkinson Disease
- How many people
- 34 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 20 May 2024to 31 Dec 2025
- How long will I take part?
- 2 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Parkinson Disease
Who may be able to join
- Hoehn \& Yahr staging ≤3 points,
- Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months,
- Those with full upper extremity shoulder flexion and abduction active joint range of motion.
Who cannot join
- Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension,
- People with any orthopedic problem that will affect the upper extremity,
- Having a secondary neurological disease diagnosis,
- Having vision impairment that may affect measurement methods (not corrected by glasses),
- Having a cognitive disease that may cause difficulty in following the researchers\' commands,
- Those who had changes in their medical use during the test (dose increase/decrease, drug change
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
İstanbul Medilife Beylikdüzü Hospital
Istanbul, 34520
Call Center, +90 (212) 866 80 80, info@medilife.com.tr
Adem Aktürk, PhD, +90 533 310 23 15, aakturk@gelisim.edu.tr
About this study
Official title: Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson\'s patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated.
- Conditions
- Parkinson Disease
- Keywords
- Parkinson, Validity, 6-Minute Pegboard and Ring Test
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 6-MPRT Group | There is 1 group in the study. All assessments are made on the same group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
6-Minute Pegboard and Ring Test
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
Measured: Baseline of the study (Assessor 1)
6-Minute Pegboard and Ring Test
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
Measured: 2 days after the baseline assessment (Assessor 1)
6-Minute Pegboard and Ring Test
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
Measured: Baseline of the study (Assessor 2)
6-Minute Pegboard and Ring Test
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
Measured: 2 days after the baseline assessment (Assessor 2)
30-Second Arm Curl Test
This test is performed with dumbbells. A 2.5-kilogram (5-pound) dumbbell is used for women and a 4-kilogram (8-pound) dumbbell for men. The test is performed in a sitting position. Patients are asked to repeat forearm flexion-supination and extension-pronation movements with the dumbbells in their hands as fast as they can for 30 seconds. The number of moves completed gives the total score.
Measured: Baseline of the study
Weight Lifting Test
This test is performed using dumbbells. Reference weights for women are 7 kg and for men are 10 kg. Patients will perform the test with each arm separately. The number of repetitions they can achieve is recorded. The test is performed standing.
Measured: Baseline of the study (Assessor 2)
Secondary outcomes (1)
Demographic Data Form
This form was created by researchers and it consist of personal informations such as gender, age, body mass index, education, duration of disease, Unified Parkinson's Disease Rating Scale, Modified Hoehn \& Yahr stage, using medicine, manual shoulder muscle strength
Measured: Baseline of the study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2024
- Study start20 May 2024
- Primary completion31 Aug 2024
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 34 participants (estimated)
- Target duration
- 2 Days
Sponsor and investigators
- Lead sponsor
- Emre Şenocak
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Emre Şenocak, Karadeniz Technical University
- Investigators
- Murat Emirzeoğlu, PhD, Study chair, Karadeniz Technical UniversityAdem Aktürk, PhD, Study chair, İstanbul Gelişim UniversityTuğba Eyigürbüz, PhD, Study chair, Bağcılar Education and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06482502
- Sponsor's protocol ID
- 2024/77
- Status last verified
- Mar 2025
- First submitted
- 26 Jun 2024
- Last updated
- 7 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 7 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
- ClinicalTrials.gov ID
- NCT06482502
- Acronym / sponsor ID
- 2024/77
- Conditions
- Parkinson Disease
- Keywords
- Parkinson, Validity, 6-Minute Pegboard and Ring Test
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 34 participants (estimated)
- Lead sponsor
- Emre ŞenocakUniversity, hospital or other
- Study start
- 20 May 2024 (actual)
- Primary completion
- 31 Aug 2024 (actual)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 1 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT), which has been validated in many respiratory disease groups in previous studies, is an endurance assessment battery that can also be used in Parkinson\'s patients. 6-MPRT, Weight Lifting Test, and 30-Second Arm Curl Test will be applied in the assessments. Assessments will be made twice on the same day by two different evaluators, 1 hour apart. After the first evaluation, the patient will be called for the second time 2 days later, and the same procedure will be repeated.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 6-MPRT Group | – | –There is 1 group in the study. All assessments are made on the same group. |
Who may qualify
- Ages
- 45 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Parkinson Disease
Key inclusion criteria (3 listed)
- Hoehn \& Yahr staging ≤3 points,
- Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months,
- Those with full upper extremity shoulder flexion and abduction active joint range of motion.
Key exclusion criteria (6 listed)
- Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension,
- People with any orthopedic problem that will affect the upper extremity,
- Having a secondary neurological disease diagnosis,
- Having vision impairment that may affect measurement methods (not corrected by glasses),
- Having a cognitive disease that may cause difficulty in following the researchers\' commands,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
6-Minute Pegboard and Ring Test
Time frame: Baseline of the study (Assessor 1)
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
6-Minute Pegboard and Ring Test
Time frame: 2 days after the baseline assessment (Assessor 1)
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
6-Minute Pegboard and Ring Test
Time frame: Baseline of the study (Assessor 2)
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
6-Minute Pegboard and Ring Test
Time frame: 2 days after the baseline assessment (Assessor 2)
The patient is in a sitting position. Opposite the patient are 4 metal rods located on a wooden table. Two of them are at shoulder level and the other two are 20 cm above shoulder level. During the test, the patient is asked to take the light rings at shoulder level with both hands at the same time and place them on the bars above. The higher the total number of rings carried indicates increased endurance.
30-Second Arm Curl Test
Time frame: Baseline of the study
This test is performed with dumbbells. A 2.5-kilogram (5-pound) dumbbell is used for women and a 4-kilogram (8-pound) dumbbell for men. The test is performed in a sitting position. Patients are asked to repeat forearm flexion-supination and extension-pronation movements with the dumbbells in their hands as fast as they can for 30 seconds. The number of moves completed gives the total score.
Weight Lifting Test
Time frame: Baseline of the study (Assessor 2)
This test is performed using dumbbells. Reference weights for women are 7 kg and for men are 10 kg. Patients will perform the test with each arm separately. The number of repetitions they can achieve is recorded. The test is performed standing.
1 secondary outcome
Demographic Data Form
Time frame: Baseline of the study
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Mar 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Murat Emirzeoğlu, PhD study chair
Karadeniz Technical University
Adem Aktürk, PhD study chair
İstanbul Gelişim University
Tuğba Eyigürbüz, PhD study chair
Bağcılar Education and Research Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinson Disease, run by Emre Şenocak at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Emre Şenocak, PhD (+90 553 569 56 92, emre.senocak@windowslive.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
6-Minute Pegboard and Ring Test (time frame: Baseline of the study (Assessor 1)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025.